Using AI to Measure Length and Weight in Infants
A Growth Artificial Intelligence Algorithm for leNgth and Weight Study
This study is testing a new AI tool that helps measure how tall and heavy babies and young kids are to see if it works better than traditional methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 0 Months to 24 Months |
| Sex | All |
| Sponsor | Nutricia Research Industry-sponsored |
| Locations | 4 sites (Rotterdam and 3 other locations) |
| Trial ID | NCT06920550 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data to improve an artificial intelligence algorithm designed for measuring the length of infants and young children. Caregivers and healthcare professionals will gather images and videos, alongside physical measurements, to train the AI and assess its accuracy against standard measurement techniques. The study also seeks to gather user experience feedback to enhance the algorithm's usability. By leveraging machine learning, the project hopes to refine the AI's predictive capabilities for growth measurements in young children.
Who should consider this trial
Good fit: Ideal candidates for this study are infants and young children aged 0 to 24 months whose caregivers can provide the necessary data using a smartphone or tablet.
Not a fit: Patients with structural abnormalities of the lower limbs or orthopedic conditions that prevent accurate length or weight measurements will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and accessible growth measurements for infants and young children, improving early health assessments.
How similar studies have performed: While the use of AI in medical measurements is an emerging field, similar studies have shown promise in enhancing measurement accuracy, though this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Infants/young children aged 0 to 24 months old at enrolment; 2. Caregiver(s) have access to the internet and a smartphone or tablet to complete questionnaires, take images and videos, and upload these; 3. Written informed consent from one or both caregivers (according to local laws) or legally acceptable representative(s) aged ≥ 18 years at enrolment. Exclusion Criteria: 1. Children unable to undergo length or weight measurements when applying standardized techniques recommended by the WHO (e.g. infants/children with structural abnormalities of the lower limbs or orthopaedic conditions (e.g. club foot, hip dysplasia)). 2. Research staff's uncertainty about the caregiver's ability or willingness to complete the study according to the instructions
Where this trial is running
Rotterdam and 3 other locations
- Franciscus Gasthuis — Rotterdam, Netherlands (Not_yet_recruiting)
- Ginemedica — Wroclaw, Poland (Not_yet_recruiting)
- Hospital Universitario Puerta del Mar — Cadiz, Spain (Recruiting)
- Hospital Universitario de Jerez dela Frontera — Jerez de la Frontera, Spain (Recruiting)
Study contacts
- Study coordinator: Danone Global Research and Innovation Center
- Email: register.clinicalresearchnutricia@danone.com
- Phone: +31 30 2095 000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.